CAH vs. IDXX: Cardinal Health vs. IDEXX Laboratories Stock Comparison

Company Profile

Cardinal Health (CAH) and IDEXX Laboratories (IDXX) both fall under the Health Care Equipment & Services industry group, but CAH is classified in Health Care Providers & Services while IDXX is classified in Health Care Equipment & Supplies.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

IDEXX Laboratories (IDXX) has an aggressive beta of 1.44, indicating higher sensitivity to broad-market moves, while Cardinal Health (CAH) is defensive at 0.49 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Capital efficiency shows on one side only: IDEXX Laboratories (IDXX) earns 68.93% on shareholders’ equity, ranked against its industry; Cardinal Health (CAH) has no ROE this period.

IDEXX Laboratories (IDXX) at 25.36% retains a top-quartile share of revenue as profit, ahead of Cardinal Health (CAH) at 0.71%, which keeps about the industry-typical share.

IDEXX Laboratories (IDXX) at 33.14% operates in the top operating margin quartile, ahead of Cardinal Health (CAH) at 1.34%, which runs around its industry’s norm.

Profitability Metrics

Growth

Both Cardinal Health (CAH) at 14.23% and IDEXX Laboratories (IDXX) at 10.42% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Both Cardinal Health (CAH) at 12.09% and IDEXX Laboratories (IDXX) at 22.59% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Growth Metrics

Financial Strength

Both Cardinal Health (CAH) at 0.89 and IDEXX Laboratories (IDXX) at 1.19 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

Only one side’s leverage can be read here: IDEXX Laboratories (IDXX) carries debt-to-equity ratio of 0.52 against its industry range, while Cardinal Health (CAH) reports no figure this period.

Financial Strength Metrics

Dividends

IDEXX Laboratories (IDXX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Cardinal Health (CAH) reports a yield of 0.77%, ranking against industry peers normally.

IDEXX Laboratories (IDXX) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Cardinal Health (CAH) reports a payout of 26.56%, ranking against industry peers normally.

Dividend Metrics

Valuation

Both Cardinal Health (CAH) at 35.15 and IDEXX Laboratories (IDXX) at 45.56 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

Cardinal Health (CAH) at 0.24 sits in the cheaper P/S ratio quartile while IDEXX Laboratories (IDXX) at 11.42 prices above its industry range — a wide gap in sales valuation between them.

Cardinal Health (CAH) reports a negative P/B ratio of -20.84, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile IDEXX Laboratories (IDXX) reports 28.50, ranking against industry peers normally.

Valuation Metrics